Recently, the National Medical Products Administration released the "2023 Medical Device Standard Development and Revision Plan Projects List" (hereinafter referred to as the "Notice"). The recommended standard formulation and revision project plan will then be formulated and RoboCT will participate in it.

The standardization not only helps to improve the safety, effectiveness and reliability of medical devices, but also plays an important role in protecting the interests and rights of patients. With further implementation of the "Notice", China's medical device standards will form its own system to guide future development.

Formulation of the recommended industry standards for "Medical Lower-limb Exoskeletons" will promote its future market competition for companies like RoboCT, which focuses on lower-limb rehabilitation exoskeleton products and services. In the long run, it will also benefit the industry as a whole Increased concentration. RoboCT also hopes to contribute its corporate wisdom, value and experience to the overall technical development of the industry through active participation.